Sort
48,018 grants matching “immunotherapy”
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$914,897Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA
Prophylactic Immunotherapy for Marburg Virus Disease Outbreak Control
$914,818M. Javad Aman · Abvacc, Inc. · R44 · FY2025 · AI
Immunotherapy for Malignant Mesothelioma
$914,751Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
$914,660Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · DK
Tissue Processing-Sequencing Facility
$914,647Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$914,594Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2009 · AI
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$914,570John F Dipersio · Washington University · R35 · FY2021 · CA
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases
$914,364James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2017 · DK
Multidisciplinary Collaborative Clinical Research, Core Facilities and Other Clinical Services in NIDDK Program Area Diseases
$914,364James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2018 · DK
Clinical Fellowship Training Program
$914,335Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2020 · CA
Targeted Therapy for Leukemia
$914,298John C Byrd · Ohio State University · R35 · FY2016 · CA
Targeted Therapy for Leukemia
$914,298John C Byrd · Ohio State University · R35 · FY2020 · CA
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$914,165Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2022 · AI
Immunotherapeutics Against Arenaviruses
$913,967Robert F Garry · Scripps Research Institute, The · U19 · FY2016 · AI
Diabetic Neuropathy Study
$913,838Peter James Dyck · Mayo Clinic Rochester · R01 · FY2007 · NS
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$913,712Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2021 · CA
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$913,712Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2020 · CA
Microfluidic CAR-T Cell Processing Device
$913,556Tony Ward · Gpb Scientific, Inc. · R42 · FY2020 · CA
Evolutionary lead optimization for immunotherapy of Marburg & Ebola viruses
$912,779Emmett Vance Schmidt · Massachusetts General Hospital · U01 · FY2006 · AI
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2015 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2017 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2020 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2021 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2016 · CA
PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
$911,531Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2021 · CA